Glucagon-like peptide-1 receptor agonists for treatment of diabetes and obesity: advantage of oral delivery
{{output}}
GLP-1 receptor agonists ((GLP-1 RAs) are currently receiving a lot of attention because of their impact in diabetes, weight loss and other areas. While GLP-1 RAs in injectable form are highly efficacious, further work is required to develop oral versions which... ...
